Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375)

Patrick R Gentry, Masaya Kokubo, Thomas M Bridges, Nathan R Kett, Joel M Harp, Hyekyung P Cho, Emery Smith, Peter Chase, Peter S Hodder, Colleen M Niswender, J Scott Daniels, P Jeffrey Conn, Michael R Wood, Craig W Lindsley

33 Citations (Scopus)

Abstract

A functional high throughput screen and subsequent multidimensional, iterative parallel synthesis effort identified the first muscarinic acetylcholine receptor (mAChR) negative allosteric modulator (NAM) selective for the M5 subtype. ML375 is a highly selective M5 NAM with submicromolar potency (human M5 IC50 = 300 nM, rat M5 IC50 = 790 nM, M1-M4 IC50 > 30 μM), excellent multispecies PK, high CNS penetration, and enantiospecific inhibition.

Original languageEnglish
JournalJournal of Medicinal Chemistry
Volume56
Issue number22
Pages (from-to)9351-5
Number of pages5
ISSN0022-2623
DOIs
Publication statusPublished - 27 Nov 2013
Externally publishedYes

Keywords

  • Allosteric Regulation/drug effects
  • Animals
  • Brain/drug effects
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Drug Discovery
  • Drug Evaluation, Preclinical
  • Humans
  • Imidazoles/chemistry
  • Indoles/chemistry
  • Male
  • Rats
  • Receptor, Muscarinic M5/chemistry
  • Structure-Activity Relationship
  • Substrate Specificity

Fingerprint

Dive into the research topics of 'Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375)'. Together they form a unique fingerprint.

Cite this